上海交通大学学报(医学版)

• 论著(临床研究) • 上一篇    下一篇

DNA修复基因XRCC3多态性与卵巢癌相关性研究的meta分析

陈平平,杨辰敏   

  1. 上海交通大学 医学院附属瑞金医院妇产科, 上海 200025
  • 出版日期:2015-05-28 发布日期:2015-06-04
  • 通讯作者: 杨辰敏, 电子信箱: ycm11185@rjh.com.cn。
  • 作者简介:陈平平(1987—),女,住院医师,硕士; 电子信箱: chenpipi1987@aliyun.com。

Correlation between polymorphisms of DNA repair gene XRCC3 and ovarian cancer: a meta-analysis

CHEN Ping-ping, YANG Chen-min   

  1. Department of Obstetrics and Gynecology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
  • Online:2015-05-28 Published:2015-06-04

摘要:

目的 研究DNA修复基因XRCC3的3种单核苷酸多态性(T241M、A4541G和A17893G)各自与卵巢癌易感性的关系并进行meta分析。方法 计算机全面检索数据库中相关文献,收集有关XRCC3基因多态性(T241M、A4541G和A17893G)与卵巢癌发病相关的病例对照研究,按照纳入文献质量评价标准,剔除不符合要求的文献,应用Stata 10.0软件计算OR及其95%CI,对各研究结果进行数据合并,比较XRCC3不同基因型以及基因多态性与卵巢癌易感性的关系,并检验一致性和评估发表偏倚。结果纳入6项研究进行meta分析,包括卵巢癌病例组5 529例,对照组8 350例,均符合HW遗传平衡。meta分析结果表明XRCC3 T241M中T和M等位基因、XRCC3 A4541G中A和G等位基因、XRCC3 A17893G中A和G等位基因在病例组和对照组的频率分布比较,差异均无统计学意义(P>0.05)。XRCC3 T241M多态性与卵巢癌的发生风险均无明显相关(P>0.05)。XRCC3 A4541G基因多态性与卵巢癌发病风险相关,其中GG/AA、GG/AG+AA、AG/AA基因型与卵巢癌发病风险相关(P<0.05;OR=0.71, 95%CI=0.56~0.90; OR=0.67, 95%CI=0.53~0.87; OR=1.06, 95%CI=1.00~1.14)。XRCC3 A17893G基因多态性与卵巢癌的发病风险相关,其中GG+AG/AA和GG/AG+AA基因型与卵巢癌发病风险相关(P<0.05;OR=0.81, 95%CI=0.79~0.84; OR=1.14, 95%CI=1.02~1.28)。结论 XRCC3 A4541G和A17893G
基因多态性与卵巢癌发病风险相关。

关键词: XRCC3基因, 单核苷酸多态性, 卵巢癌, 易感性, meta分析

Abstract:

Objective To explore the correlation between three polymorphisms (T241M, A4541G, and A17893G) of DNA repair gene XRCC3 and susceptibility to ovarian cancer and conduct meta-analysis. Methods Case-control studies on the relationship between polymorphisms of gene XRCC3 (T241M, A4541G, and A17893G) and the incidence of ovarian cancer were collected by comprehensively retrieving relevant literature from databases. Unqualified papers were removed according to the quality evaluation criteria for selecting literature. Values of OR and 95%CI were calculated by Stata 10.0 and data of research results were merged. The correlation of different genotypes and polymorphisms of gene XRCC3 and the susceptibility to ovarian cancer was compared. The consistence and publication bias were evaluated. Results The meta-analysis was conducted for 6 studies, including the ovarian cancer group (n=5 529) and control group (n=8 350) which met the H-W genetic equilibrium. Results of meta-analysis showed that the differences of frequency distribution of allelotypes T and M of XRCC3 T241M, A and G of XRCC3 A4541G, and A and G of XRCC3 A17893G of the ovarian cancer group and control group were not statistically significant (P>0.05). The polymorphisms of XRCC3 T241M were not significantly correlated with the incidence of ovarian cancer (P>0.05). The polymorphisms of XRCC3 A4541G were correlated with the incidence of
ovarian cancer and genotypes GG/AA, GG/AG+AA, and AG/AA were correlated with the incidence of ovarian cancer (P<0.05; OR=0.71, 95%CI=0.56-0.90; OR=0.67, 95%CI=0.53-0.87; OR=1.06, 95%CI=1.00-1.14). The polymorphisms of XRCC3 A17893G were correlated with the incidence of ovarian cancer and genotypes GG+AG/AA and GG/AG+AA were correlated with the incidence of ovarian cancer (P<0.05; OR=0.81, 95%CI=0.79-0.84; OR=1.14, 95%CI=1.02-1.28). Conclusion Polymorphisms of XRCC3 A4541G and A17893G are correlated with the incidence of ovarian cancer.

Key words: gene XRCC3, polymorphisms, ovarian cancer, susceptibility, meta-analysis